Thanks for an outstanding conference!

 Join us in 2020!
Your Subtitle text
For Immediate Release

Contact: Michael Glynn
Weston Medical Publishing, LLC
781-899-2702 ext 103 or 781-647-7800 (cell)

The Future of Opioids:
Pain Management and the Public Health

Boston, MA – June 7, 2019 – The eighth annual International Conference on Opioids (ICOO 2019), is being held June 9-11, 2019, at the Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA. 

The conference will explore emerging opioid research and clinical applications aimed at improving patient care, reducing risk and addressing the current opioid epidemic. Over three days, cutting-edge topics on opioids will be presented by a wide range of world-renowned presenters including these keynote speakers:

Alan R. Gintzler, PhD, Professor, Biochemistry Neurobiology of Pain and Addiction Research Department of Obstetrics and Gynecology, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Gintzler will address how unraveling the complex mechanisms that are used to regulate the utilization of endogenous opioids could provide a new template for opioid therapy in his presentation "Pain Management in the Era of the Opioid Crisis: A New Approach for Providing Opioid Antinociception While Avoiding Abuse."

Gregory A. Acampora, MD, Professor of Medicine; Associate Dean of Continuing Medical Education, Director, Safe and Competent Opioid Prescribing Education (SCOPE of Pain), Boston University School of Medicine, Boston, Massachusetts. Dr. Acampora will review both risks and benefits of prescribed opioids and benzodiazepines in the treatment of patients with chronic pain in his presentation of "Comorbid Use of Opioids and Benzodiazepines in Chronic Pain Patients."

Mary Jeanne Kreek, MD, Senior Attending Physician, Patrick E. and Beatrice M. Haggerty Professor, Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York. Dr. Kreek will explain how two extremely effective medications (each combined with counseling), methadone maintenance (currently used to treat 1.4 million persons worldwide) and buprenorphine-naloxone (sublingual) are used for chronic opiate addiction as she presents the Gavril Pasternak Memorial Keynote entitled "Methadone and Buprenorphine Maintenance: Effective Treatments for Opiate Addiction.".

Bertha K. Madras, PhD, Professor of Psychobiology, Harvard Medical School, Director, Laboratory of Addiction Neurobiology, McLean Hospital, Boston, Massachusetts. Dr. Madras was Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy, a presidential appointment confirmed unanimously by the US Senate, and was appointed as one of six members of the President’s Commission on Combating Drug Addiction and the Opioid Crisis. She will highlight the key points of the commission's final report in "The Opioid Crisis: Made in America: Fade in America?"

"Now in our eighth year, we have been able to host renowned thought-leaders in opioid therapies," says Paul A. Sloan, MD, Editor-in-Chief of the Journal of Opioid Management, presenter of the conference, “International Conference on Opioids is making a positive difference in how clinicians prescribe opioids for their patients. To date, nearly 2,000 medical professionals have attended the conference. We expect a full conference this year and vigorous debate about the future of opioids in medicine."

The 2019 International Conference on Opioids has assembled the best and brightest minds in opioid analgesics who will explore the challenges of using opioids to treat pain. They will present the latest research, real world knowledge, and practical solutions aimed at improving patient outcomes and reducing risk to both your patients and your practice. Researchers, educators, practitioners, and policymakers are all intently working to address this challenge.

"Taken as prescribed, opioids can be used to manage pain safely and effectively. However, when abused, even a single large dose can cause severe respiratory depression and death".1 Opioid drug abuse is the Nation's fastest-growing drug problem and is classified as an epidemic by the Centers for Disease Control and Prevention. Education for prescribers is the key to effective opioid use and avoidance of misuse, abuse, addiction, and death. “We are fortunate to have the most impressive gathering of opioid experts anywhere this year,” says Jianren Mao, MD, PhD conference co-chair.

The International Conference on Opioids (, presented by the Journal of Opioid Management, provides a unique forum to address the proper and responsible use of opioids and the growing problems associated with misuse, abuse and addiction. "We plan an evidence-based educational conference" added Dr. Mao, "and look to provide the latest research on opioids, as well as a spirited debate on the future of opioid therapies."

For further information, please contact Michael J. Glynn, International Conference on Opioids, 781-899-2702, ext 103 or 781-647-7800, or

The Journal of Opioid Management ( is the only professional, peer-reviewed journal focused exclusively on the safe and responsible use of opioids. With an editorial staff and review board of the world's leading experts in the field, the Journal provides guidance to physicians and healthcare professionals on how to safely prescribe and responsibly manage these drugs. The Journal of Opioid Management, ISSN 1551-7489, is published bi-monthly by Weston Medical Publishing, LLC.

1. NIDA. (2015). Health, United States. Retrieved from National Institute on Drug Abuse: